China Boycotts Actor after Photos of Visit to Japan’s Yasukuni Shrine

China’s Association of Performing Arts on Sunday called for a boycott of a Chinese actor after photos of him at Japan’s controversial Yasukuni Shrine taken in 2018 and 2019 emerged. (Reuters)
China’s Association of Performing Arts on Sunday called for a boycott of a Chinese actor after photos of him at Japan’s controversial Yasukuni Shrine taken in 2018 and 2019 emerged. (Reuters)
TT

China Boycotts Actor after Photos of Visit to Japan’s Yasukuni Shrine

China’s Association of Performing Arts on Sunday called for a boycott of a Chinese actor after photos of him at Japan’s controversial Yasukuni Shrine taken in 2018 and 2019 emerged. (Reuters)
China’s Association of Performing Arts on Sunday called for a boycott of a Chinese actor after photos of him at Japan’s controversial Yasukuni Shrine taken in 2018 and 2019 emerged. (Reuters)

China’s Association of Performing Arts on Sunday called for a boycott of a Chinese actor after photos of him at Japan’s controversial Yasukuni Shrine taken in 2018 and 2019 circulated online and sparked outrage among Chinese netizens and media.

The Yasukuni Shrine is seen by Japan’s neighboring countries as a symbol of that country’s past militarism, and remains a flashpoint for tension with China.

The shrine honors Japan’s war dead, including 14 World War Two leaders convicted by an Allied tribunal as war criminals. China, which was occupied by the Japanese from 1937 to 1945, takes offence at visits to the shrine.

“The misbehavior of actor Zhang Zhehan severely harms national feeling and brings baneful influence to his young age-group audience. Hence, we demand members not to engage him in any employment,” said the association in a statement on Sunday.

Zhang, 30, apologized on Chinese social media on Friday saying he is “ashamed of his ignorance”. Still, state-backed People’s Daily commented that Zhang should “pay a heavy price” for the “challenge of national dignity”.

More than 25 companies in China, including US beverage maker Coca-Cola Co and Danish jeweler Pandora A/S, have announced the termination of partnerships with Zhang.

Separately, China protested on Friday a visit to the shrine by Japanese Defense Minister Nobuo Kishi.

Chinese Defense Ministry spokesman Wu Qian told reporters China was “greatly dissatisfied and firmly opposed” to the visit.

The visit showed “the wrong attitude with how Japan treated its history of invasion and its malicious intention in challenging the post-war international order,” Wu said.

China has lodged stern representation to Japan on this matter, Wu said.



‘Venom: The Last Dance’ Misses Projections as Superhero Films’ Grip on Theaters Loosens

 Tom Hardy poses for photographers upon arrival at the premiere of the film "Venom: The Last Dance" on Wednesday, Oct. 23, 2024, in London. (AP)
Tom Hardy poses for photographers upon arrival at the premiere of the film "Venom: The Last Dance" on Wednesday, Oct. 23, 2024, in London. (AP)
TT

‘Venom: The Last Dance’ Misses Projections as Superhero Films’ Grip on Theaters Loosens

 Tom Hardy poses for photographers upon arrival at the premiere of the film "Venom: The Last Dance" on Wednesday, Oct. 23, 2024, in London. (AP)
Tom Hardy poses for photographers upon arrival at the premiere of the film "Venom: The Last Dance" on Wednesday, Oct. 23, 2024, in London. (AP)

“Venom: The Last Dance” showed less bite than expected at the box office, collecting $51 million in its opening weekend, according to studio estimates Sunday, significantly down from the alien symbiote franchise’s previous entries.

Projections for the third “Venom” film from Sony Pictures had been closer to $65 million. More concerning, though, was the drop off from the first two “Venom” films. The 2018 original debuted with $80.2 million, while the 2021 follow-up, “Venom: Let There Be Carnage,” opened with $90 million even as theaters were still in recovery mode during the pandemic.

“The Last Dance,” starring Tom Hardy as a journalist who shares his body with an alien entity also voiced by Hardy, could still turn a profit for Sony. Its production budget, not accounting for promotion and marketing, was about $120 million — significantly less than most comic-book films.

But “The Last Dance” is also performing better overseas. Internationally, “Venom: The Last Dance” collected $124 million over the weekend, including $46 million over five days of release in China. That’s good enough for one of the best international weekends of the year for a Hollywood release.

Still, neither reviews (36% fresh on Rotten Tomatoes) nor audience scores (a franchise-low “B-” CinemaScore) have been good for the film scripted by Kelly Marcel and Hardy, and directed by Marcel.

The low weekend for “Venom: The Last Dance” also likely ensures that superhero films will see their lowest-grossing year in a dozen years, not counting the pandemic year of 2020, according to David A. Gross, a film consultant who publishes a newsletter for Franchise Entertainment.

Following on the heels of the “Joker: Folie à Deux” flop, Gross estimates that 2024 superhero films will gross about $2.25 billion worldwide. The only upcoming entry is Marvel’s “Kraven the Hunter,” due out Dec. 13.

Even with the $1.3 billion of “Deadpool & Wolverine,” the genre hasn’t, overall, been dominating the way it once did. In 2018, for example, superhero films accounted for more than $7 billion in global ticket sales.

Last week’s top film, the Paramount Pictures horror sequel “Smile 2,” dropped to second place with $9.4 million. That brings its two-week total to $83.7 million worldwide.

The weekend’s biggest success story might have been “Conclave,” the papal thriller starring Ralph Fiennes and directed by Edward Berger (“All Quiet on the Western Front”). The Focus Features release, a major Oscar contender, launched with $6.5 million in 1,753 theaters.

That put “Conclave” into third place, making it the rare adult-oriented drama to make a mark theatrically. Some 77% of ticket buyers were over the age of 35, Focus said. With a strong opening and stellar reviews, “Conclave” could continue to gather momentum both with moviegoers and Oscar voters.